Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-11

Clinical Trial Update: Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study) [Phase 3]

View source ↗

Summary

A Phase 3 trial (CONVICT) evaluating whether combining nicotine replacement therapy with varenicline improves tobacco cessation outcomes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotine replacement therapy (NRT) (nicotine)
  • Varenicline (varenicline)

Snippet

Sponsor: Queen Mary University of London | Conditions: Tobacco Dependence, Smoking Cessation | Phase 3 | Status: COMPLETED